<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Survivin (Surv) belongs to the inhibitor of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> protein family </plain></SENT>
<SENT sid="1" pm="."><plain>Its cardiac-specific deletion results in reduced cardiomyocyte number, increased cardiomyocyte size and ploidy, and development of <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Its impact on cardiac electrophysiology is unknown </plain></SENT>
<SENT sid="3" pm="."><plain>In vivo transvenous electrophysiological studies were carried out in adult male mice with a cardiac-specific deletion of survivin (Surv(-/-); n = 12) and <z:mp ids='MP_0002169'>wild-type</z:mp> controls (Surv(+/+); n = 12) </plain></SENT>
<SENT sid="4" pm="."><plain>Epicardial activation mapping (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>) was performed in Langendorff-perfused hearts of 16 Surv(-/-) and 6 Surv(+/+) mice </plain></SENT>
<SENT sid="5" pm="."><plain>Surface-ECG showed lower heart rates in Surv(-/-) mice (326 ± 66 bpm vs. 440.6 ± 39 ms; P = 0.0001), accompanied by significantly <z:mp ids='MP_0004071'>prolonged P waves</z:mp> (20.3 ± 5.8 vs. 14.6 ± 2.0 ms; P = 0.009), PQ-(47.4 ± 8.6 vs. 41.1 ± 3.7 ms; P = 0.043), QRS- (19.5 ± 4.8 vs. 14.0 ± 1.0 ms; P = 0.002) and QT-intervals (41.6 ± 4.4 vs. 36.2 ± 3.4 ms; P = 0.003) </plain></SENT>
<SENT sid="6" pm="."><plain>The HV-interval was prolonged in Surv(-/-) mice (12.1 ± 2.4 vs. 9.3 ± 1.4 ms; P = 0.0045) </plain></SENT>
<SENT sid="7" pm="."><plain>We found impaired sinus-nodal function (sinus node recovery times: 310.2 ± 76.6 vs. 207.8 ± 68.6 ms; P = 0.003) and AV-nodal conduction (<z:e sem="disease" ids="C0264907" disease_type="Disease or Syndrome" abbrv="">Wenckebach</z:e>-periodicity: 105.9 ± 15.9 vs. 79.6 ± 8.1 ms; P = 0.0002) </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> showed significant slowing and <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of conduction in the myocardium of Surv(-/-) mice </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> Surv(-/-) mice showed spontaneous supraventricular and <z:mp ids='MP_0009732'>ventricular ectopic beats</z:mp> (P &lt; 0.0001 vs. <z:mp ids='MP_0002169'>wildtype</z:mp>) </plain></SENT>
<SENT sid="10" pm="."><plain>Quantitative immunofluorescence staining for connexin43 (Cx43) revealed a decrease in both per cardiomyocyte and single gap junction </plain></SENT>
<SENT sid="11" pm="."><plain>Surv(-/-) mice exhibit severe global conduction attenuations in atrial and ventricular myocardium as well as the specific conduction system, accompanied by lower connexin43 levels </plain></SENT>
<SENT sid="12" pm="."><plain>Lack of susceptibility to AF and VT suggests that reduced cardiomyocyte number and <z:mp ids='MP_0001264'>increased size</z:mp> constitute determinants of electrical stableness in the heart and counteract potentially proarrhythmogenic connexin43 loss in Surv(-/-) </plain></SENT>
</text></document>